DEFENSIN THERAPEUTICS ApS — Credit Rating and Financial Key Figures
CVR number: 35513280
Rigensgade 11 A, 1316 København K
pno@defensintherapeutics.com
tel: 25471646
www.defensintherapeutics.com
Income statement (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Fiscal period length | 12 | 12 | 12 | 12 | 12 |
Net sales | |||||
Other operating income | 400.00 | ||||
Gross profit | 400.00 | ||||
Costs of management | - 179.70 | - 112.05 | - 167.81 | -98.98 | - 116.12 |
Other operating expenses | -1 654.07 | -2 189.21 | - 575.51 | - 370.79 | - 305.17 |
EBIT | -1 833.77 | -2 301.26 | - 343.32 | - 469.77 | - 421.30 |
Other financial income | 0.05 | ||||
Other financial expenses | -18.88 | -23.46 | -26.95 | -19.20 | -4.05 |
Pre-tax profit | -1 852.65 | -2 324.72 | - 370.27 | - 488.92 | - 425.34 |
Income taxes | 131.54 | 9.04 | 4.66 | 15.03 | |
Net earnings | -1 721.11 | -2 315.68 | - 365.61 | - 473.89 | - 425.34 |
Assets (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Intangible assets total | |||||
Tangible assets total | |||||
Investments total | |||||
Long term receivables total | |||||
Inventories total | |||||
Prepayments and accrued income | 7.37 | 8.11 | 8.92 | 9.81 | 8.92 |
Current other receivables | 94.67 | 85.98 | 47.05 | 36.43 | 173.05 |
Current deferred tax assets | 131.54 | 9.04 | 13.70 | 15.03 | |
Short term receivables total | 233.58 | 103.13 | 69.67 | 61.27 | 181.97 |
Cash and bank deposits | 4 808.10 | 2 595.52 | 2 110.02 | 1 703.77 | 1 227.68 |
Cash and cash equivalents | 4 808.10 | 2 595.52 | 2 110.02 | 1 703.77 | 1 227.68 |
Balance sheet total (assets) | 5 041.68 | 2 698.65 | 2 179.69 | 1 765.04 | 1 409.66 |
Equity and liabilities (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Share capital | 1 261.38 | 1 261.38 | 1 261.38 | 1 261.38 | 1 261.38 |
Other restricted equity | 137.50 | ||||
Retained earnings | 5 282.91 | 3 561.80 | 1 246.12 | 880.51 | 406.62 |
Profit of the financial year | -1 721.11 | -2 315.68 | - 365.61 | - 473.89 | - 425.34 |
Shareholders equity total | 4 823.18 | 2 507.50 | 2 141.89 | 1 668.00 | 1 380.15 |
Non-current liabilities total | |||||
Current trade creditors | 198.90 | 170.85 | 32.80 | 97.04 | 29.50 |
Other non-interest bearing current liabilities | 19.60 | 20.30 | 5.00 | ||
Current liabilities total | 218.50 | 191.15 | 37.80 | 97.04 | 29.50 |
Balance sheet total (liabilities) | 5 041.68 | 2 698.65 | 2 179.69 | 1 765.04 | 1 409.66 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions

... and more!
No registration needed.